Suess Microtec SE (0Q3C)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 49.38 |
|---|---|
| 52-week range | 25.82 – 118.40 |
| Return, 1 month / 3 months | −33.5% / −40.9% |
| Return, 1 year / 3 years | +40.6% / +140.2% |
| Trend | Below its 200-day average |
| RSI (14) | 25 |
| Volatility (1 year) | 73.4% |
| Worst drawdown (1 year) | -55.8% |
| Average daily value traded | 1.28M EUR |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SUSS MicroTec SE supplies equipment and process solutions for the semiconductor and microelectronics industries. The company builds machines used in lithography, coating, developing, and wafer bonding, along with related services and spare parts. Its customers are chipmakers, research institutes, and microelectronics manufacturers that need precision tools for fabricating devices. SUSS MicroTec is based in Garching near Munich, Germany, and its products support production and development work in microtechnology.
Suess Microtec SE trades under the code 0Q3C on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Suess Microtec SE (0Q3C) trades on the London Exchange in UK. It last closed at EUR 49.38 on 23 October 2026.
Its price-based Market X-Ray is 28 out of 100 (a weak price profile), ranking 3,152 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.6% and over the last three months it fell 40.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 19 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -29.4% | ||
| From 52-week high | -55.8% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -40.9% | ||
| 6-month return | -28.9% | ||
| 12-month return, skipping the last month | 111.5% | ||
| Stability (higher is calmer) | 14 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.8% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −12.8% |
|---|---|
| 1 month | −33.5% |
| 3 months | −40.9% |
| 6 months | −28.9% |
| 1 year | +40.6% |
| 3 years | +140.2% |
| 5 years | +135.4% |
Signals
| 50-day / 200-day average | 68.48 / 69.98 |
|---|---|
| Golden / death cross (60 days) | Death, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.35 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.0400 |
| 4 Jun 2025 | EUR 0.3000 |
| 12 Jun 2024 | EUR 0.2000 |
| 1 Jun 2023 | EUR 0.2000 |
| 1 Jun 2022 | EUR 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.